The Executive Committee is the decision making body for the PMIX Working Group. The Executive Committee is responsible for development, modification and support of the PMIX Architecture’s standards, guidelines and policies. The PMIX Executive Committee is comprised of two elected representatives and an alternate from four regions.

  • Define the goals and direction of the PMIX Working Group and provide for the development and maintenance of the PMIX
  • Establish goals and objectives for the architecture roadmap in order to keep it current with changes in technology, relevant to the needs for information exchange between PDMPs and their partner organizations and aligned with the business goals and objectives and statutory requirements of the Prescription Drug Monitoring programs
  • Evaluate the PMIX Working Group effectiveness and functions
  • Oversee the appointment and operations of all subcommittees
  • Attend Executive Committee meetings and ensure the Executive Committee and Subcommittees are accomplishing their goals
  • Facilitate the process via which all PDMP Organizations may review and provide feedback on the proposed changes to the PMIX National Architecture
  • Review the operational cost effectiveness of changes to the PMIX National Architecture
  • Address new opportunities for information exchange
  • Identify and define any procedures needed to facilitate the business of the PMIX Working Group
  • Determine the methods by and the media through which meetings pursuant to section 4.06 are conducted
  • Establish criteria and measurements of conformance to the PMIX architecture